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The dysplastic naevus
Wolter J Mooi
Since the dysplastic naevus (DN) syndrome
was first described,' 2 its marker lesion, the
DN, has been subject of vehement debate.
Major disagreements concerning its macro-
scopic and microscopic characteristics, its
prevalence, its relation to melanoma, its
treatment, and indeed its very existence as a
separate entity, have continued for two dec-
ades. As a result, some have dismissed the
entire matter as unsolvable. Some now prefer
alternative or related terms such as atypical
mole or an eponymic designation, or have
included severely dysplastic naevi in a category
of melanocytic intrapidermal neoplasia
(MIN)."' Others have continued to maintain
that the dysplastic naevus is a distinct entity,
which can-and should be distinguished from
other naevus types and from melanoma.5 6
Here, an attempt is made to analyse some of
the causes of this controversy, with special
emphasis on the relation between the predic-
tive value of diagnostic criteria of entities
entering the differential diagnosis and the rela-
tive prevalence of these entities. Arguments in
favour of the continued use ofDN as a separate
entity will be provided, and practical guidelines
for its diagnosis will be summarised.
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Historical background
In the late 1 970s, reports emerged of a familial
syndrome characterised by multiple and ab-
normal naevi, associated with a very high risk
ofmelanoma.' 2 In families with the "dysplastic
naevus syndrome", the clinical phenotype and
melanoma risk were found to segregate with an
autosomal dominant pattern of inheritance,
suggesting the presence of a single causative
gene.
The abnormal naevi, which were initially
considered diagnostic of this familial dysplastic
naevus syndrome, or FAMMM (familial atypi-
cal multiple mole melanoma)7 syndrome, were
soon also recognised in patients with a similar
clinical phenotype of multiple abnormal moles,
often in association with melanoma, but with a
negative family history.8 Controversy regarding
their significance as melanoma risk markers
arose when they were also identified as solitary
lesions in otherwise unremarkable individuals;
indeed, solitary atypical naevi were noted in
2-9% or even more of the general
population.9-'3 Indeed, to some degree, the
clinical and histological features of DN were
found to be related to endogenous (endocrine)
or exogenous (solar irradiation) stimuli,'4"
blurring the distinction between DN and other
common acquired naevi.
Unfortunately, different authors applied dif-
ferent criteria for the clinical and histological
diagnosis of DN. These differences preclude a
detailed comparison of data from different
series and a conclusion with respect to the
apparent discrepancies between series. Several
attempts at consensus met with only partial
success, as is apparent from the differences in
diagnostic criteria that continue to be used.
Usefulness of the terms dysplasia and DN
The term dysplastic naevus has been repeat-
edly criticised.'6 '7 In pathology, the term
dysplasia is used in very different ways-for
example, dysplastic goiter, dysplasia of the
uterine cervix, bronchopulmonary dysplasia.
Therefore, is was argued, the term would be
too ambiguous to be used at all. However, it
should be borne in mind that in all language,
including scientific language, words have dif-
ferent meanings in different contexts. The con-
text defines its meaning in the individual
instance. Indeed, the word mole may refer to an
animal or a cutaneous pigmented lesion. The
term dysplasia in the context of naevi indicates a
combination of cellular and architectural ir-
regularities, described in detail below, and
associated to varying degrees (depending
primarily on clinical context) with increased
melanoma risk.
Nonetheless, some dermatologists and pa-
thologists now favour alternative designations
such as atypical mole. However, the words
atypical and mole are at least as varied in their
meaning as is the word dysplastic. The term
melanocytic intraepidermal neoplasia (MIN),
which lumps together severely dysplastic naevi
and in situ melanoma,3 has the advantage of
abolishing the problem ridden histological dis-
tinction between DN and in situ melanoma, a
distinction that has no apparent clinical
relevance, but has other disadvantages. Very
severely dysplastic DN are compound rather
than intraepidermal, and the term neoplasia
would also be applicable to other naevus types.
In my opinion, the term DN remains the best
choice.
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Figure 1 Dysplastic compound naevus. Irregular distribution melanocytes arranged in
nests and lentiginous patterns along the dermoepidermal junction. Irregular rete ridges, in
part surrounded by lamellar sclerosis. Slightly irregular distribution of intradermal
melanocytic nests and smaller cell groups.
. .
Figure 2 Dysplastic compound naevus. Irregular rete ridges, surrounded by pronounced
lamellar sclerosis.
Morphology of the DN
The macroscopical features of the DN are best
evaluated before removal. DN are roughly
symmetrical, flat or slightly raised pigmented
lesions, or they may have a slightly papular
centre surrounded by a flat rim. Most are over
6 mm in diameter. DN are not verrucous or
pendulous. The peripheral border is often
blurred and slightly irregular, and the lesion is
surrounded by a reddish hue, caused by
reactive hyperaemia; this feature is no longer
evaluable after excision. The pigmentation may
be slightly irregular in intensity and colour. In
DN syndrome patients, DN are often numer-
ous and occur in sites where naevi are generally
absent or scarce, such as the buttocks, breasts,
genital skin, and dorsa of feet. Occasionally, a
DN syndrome patient may have fewer than 10
clinically evident DN.
The histological diagnosis ofDN is based on
a combination of cytological and architectural
features, including a characteristic host re-
sponse. It is advised that the diagnosis of DN
should not be made when the lesion is smaller
than 5 mm in diameter clinically'8 or 4 mm
across on the slide. This is because a large
number of small naevi, at an early stage of their
development when still only a few millimetres
in diameter, exhibit some or many of the histo-
logical features of DN, especially irregular
nesting with occasional rete ridge bridging, as
well as lamellar subepidermal sclerosis. It is the
combination of larger size and the histology
that characterises DN.
ARCHITECTURAL FEATURES
Most DN are compound, possessing a junc-
tional and an intradermal component. A small
minority of DN are entirely junctional. No
intradermal DN is recognised. Compound
dysplastic naevi often have a slightly raised
centre and a flat periphery, which consists of
junctional lateral spread of the proliferation,
associated with irregular rete ridge elongation
and subepidermal sclerosis (fig 1), often
consisting of stacks of slightly refractile colla-
gen fibres (lamellar fibrosis; fig 2).
The junctional component generally consists
of nests as well as solitary cells arranged in a
lentiginous pattern. The nests are irregularly
sized and shaped, and often have a horizontal
orientation bridging adjacent epidermal rete
ridges. The lentiginous proliferations of
melanocytes are similarly irregularly distrib-
uted (fig 1). The junctional component is
highly cellular, in areas replacing the large
majority ofbasal epidermal keratinocytes. Both
nests and lentiginous proliferations usually
extend somewhat along the epithelium of cuta-
neous adnexae. Mitotic figures are rare. Ascent
of solitary melanocytes so that these cells reach
the granular layer is also absent or rare in DN.
If present, the ascending cells are small, with
compact, dark nuclei, and little cytoplasm.
The dermal component of dysplastic com-
pound naevi is located at the centre, so that the
lesion is symmetrical. Generally, well defined
nests and strands of melanocytes predominate
in the subepidermal part, which exhibits
distinct sclerotic changes. Deeper parts of the
naevus consist of ill defined aggregates or, less
commonly, more compact small groups of
cells. Larger, compact, spherical intradermal
nodules are absent-their presence should
raise a strong suspicion of (vertical growth
phase) melanoma. Melanocytes at the base of
the lesion are usually small but may be
pigmented. Generally, the intradermal compo-
nent ofDN is not very extensive.
The dysplastic naevus exhibits a characteris-
tic host response, consisting of irregular rete
ridge elongation, together with subepidermal
sclerosis, which takes the shape of dense,
refractile stacks of collagen fibres around rete
ridges and along capillaries of dermal papillae.
Proliferation of dermal capillaries and a
perivascular lymphohistiocytic inflammatory
infiltrate are invariably present.
Importantly, the architectural and cellular
features of different parts of the naevus are
similar-at any level of the lesion, the cell type
is similar throughout. In this, the DN resem-
bles most other naevus types, and is distinct
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Figure 3 Dysplastic compound naevus (detail offig 2). Note irregular distribution oJ
junctional melanocytes, associated with distinct anisonucleosis.
from most melanomas, which exhibit n
variation in architecture and cellular featui
CYTOLOGICAL FEATURES
The melanocytes ofDN exhibit nuclear at3
especially nuclear pleomorphism and ar
chromatism, most obvious at the dermoepi
mal junction and in the subepidermal re
(fig 3). Such nuclear atypia is a prerequisit
a positive diagnosis of DN.'9 It is the varial
in size, shape, and staining intensity of
nuclei, rather than their absolute size, th
most characteristic ofDN. Nuclei ofmelan
tes in Spitz naevi, pigmented spindle cell n;
blue naevi, and deep penetrating naevi ma
large, but in these latter naevus types, the e
ability of nuclear features is less striking tha
a DN. In contrast to most melanomas,
nuclear pleomorphism is similar in diffe
areas of the lesion. In melanoma, there is c
a difference in nuclear features between di
ent nests or aggregates.
In my experience, the presence of dusty
ment in junctional melanocytes is of little p
tical use in the differential diagnosis, as it
also be present in melanoma as well as in s
common acquired naevi, Spitz naevi, (
penetrating naevi, and balloon cell n
Intradermal mitotic figures are abseni
exceedingly rare. Their presence should ra
suspicion of melanoma.
None of the histological features ofDN
have been put forward is diagnostic by its
it is a combination of features, rather than
single feature in isolation, that sets apart t
naevi. If used in this way, there is a fair cor:
tion between the histological and clinical
nosis of DN.2'
As each of the features relevant to
diagnosis of DN can be present to var
degrees, and in various combinati
classification problems of borderline cases
unavoidable. This is especially problen
with respect to the differential diagr
between common acquired naevus and
Obviously, the combination of distinct cyto-
* logical and architectural atypical features in a
naevus of an affected familial DN syndrome
patient does not provide major diagnostic diffi-
culties. However, such cases are rare in
comparison to the very large number of naevi
e with only some of these features, occurring in
otherwise unremarkable individuals. It is clear
that a restrictive diagnostic approach to DN
will exclude the large majority of these latter
* lesions.
4tj The grading of dysplasia in DN is advocated
* by some workers; however, since it results in
significant intraobserver and interobserver
variability,22 23 I have discontinued grading DN.
I Relative prevalence of entities v
predictive value of diagnostic criteria
F8 An important consideration, often overlooked
in discussions on the practical value of
diagnostic criteria, is the profound impact of
the relative prevalence of two entities requiring
differentiation, on the predictive value of a
given criterion used to differentiate the two.24
nore In other words, a feature, or a combination of
res. features, needs to have a very high specificity if
it is to be of use in the positive identification of
a rare entity.
ypia, This is probably of central relevance to the
controversy on dysplastic naevi. Naevi submit-
,5so ted for histology constitute a very smalldeOr- proportion of the naevi in the general popula-
tion. The reason for removal is usually either
e for
cosmetic or a suspicion of melanoma. Slides
~lthe referred for expert opinion reflect a substantialthe bias, the numbers of problem cases, including
at is DN, is much higher in such series. Signifi-
aocy- cantly, published series used for the study of
ayvbe interobserver variability in the diagnosis ofDNy ne have included relatively large numbers ofvarni DN,14 22 25 26 which contrasts with the material
in in received in general diagnostic pathology labo-the
ratories where non-dysplastic naevi greatly
rfent outnumber DN. In these latter diagnosticften pathology laboratories, a problem of insuffi-ffer- cient specificity of diagnostic criteria for DN is
encountered; this problem is masked to a con-
pig- siderable extent in studies based on selected)rac-
material in which DN are greatly overrepre-
may sented. To avoid this problem, as far as possible
~ome
deep a conservative approach in the diagnosis ofDN
aevi is advised: only those naevi 6 mm or larger in
aevi. diameter and meeting the combination of the
tsor cytological and architectural abnormalitiesise a summarised above should be designated DN.
that
elf,20 Dysplastic naevus v early melanoma
any The distinction between DN and melanoma is
hese of greater importance clinically than between
rela- DN and common acquired naevi. A number of
liag- negative findings is of central importance in the
distinction of DN from small melanomas. In
the DN, there is no pagetoid spread of atypical
*ious melanocytes at all levels of the epidermis,
ions, across most or all of the lesion. Moreover,
s are intradermal mitoses are absent, unless a brisk
natic inflammatory infiltrate permeates the dermal
nosis part of the lesion. Atypical mitotic figures are
DN. invariably absent. Distinct differences in pres-
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ence, degree or aspect of inflammation and
fibrosis between different areas ofthe lesion are
lacking in DN.
The malignant potential of many thin,
presumably early, melanomas as they are diag-
nosed today is far from clear. The question
arises: are these so called early melanomas
really melanomas-that is, fully malignant
tumours that were discovered in time, or do
they only resemble melanoma, clinically and
histologically, but need further steps before the
potential to invade and metastasise is acquired?
Follow up data of the large material of Elder et
al"7 and Clark et al'5 indicate that radial growth
phase melanomas never metastasise. Although
independent confirmation of their conclusions
is necessary before the acceptance of radial and
vertical growth phase melanoma as diagnostic
concepts, their findings raise an interesting
point: if there is a phase in which a melanoma
never metastasizes, it would seem to be appro-
priate to conclude that at this stage the lesion
may be a precursor lesion of malignancy, but
has not yet acquired a fully malignant pheno-
type, and therefore is not really an early
melanoma. Further studies on thin metastasis-
ing melanomas are essential to identify small
melanomas with a greater degree of precision,
and to attain a greater degree of confidence in
excluding the diagnosis of melanoma in thin
worrisome lesions. The outcome of such ongo-
ing work will no doubt contribute significantly
to the distinction between DN and melanoma.
The practical role ofthe pathologist in
the diagnosis of dysplastic naevi
Early reports on DN seemed to indicate that
the histopathologist would be able to identify
with considerable reliability a naevus type that,
regardless of clinical context, would constitute
a marker of clinically significant melanoma
risk. Clearly, this is not the case. It is the clini-
cal evaluation (numbers, distribution and mac-
roscopic appearance of the patient's naevi, and
family history) that is the best basis for the
diagnosis and clinical management of the DN
syndrome. It should, however, be borne in
mind that the clinical reproducibility ofDN, as
shown by recent interobserver variability stud-
ies based on photographs of single naevi, is
limited.29 30 The primary task of the histo-
pathologist, with respect to DN, is to rule out
melanoma. A patient with the clinical pheno-
type of the DN syndrome should be carefully
monitored and excessive exposure to sunlight
should be avoided. Prophylactic removal of all
DN is a futile exercise, DN continue to arise,
change in appearance, and disappear through-
out adult life.3' 32 A change in size or appear-
ance of a previously stable naevus raises a sus-
picion of malignant transformation and should
lead to excision of the lesion. The practical rel-
evant question in such an instance is not, is the
naevus dysplastic? but rather, is the lesion a
melanoma?
If the pathologist diagnoses a DN, it is wise
to add a note in the report indicating that this
finding per se does not imply that the patient
has a significant risk for melanoma, but that a
proper clinical evaluation of the numbers, dis-
tribution, and appearance of naevi across the
entire skin is advised. If the clinical findings are
within normal limits, the diagnosis apparently
has no obvious further consequences.
Conclusions
From the above, a number of conclusions can
be drawn:
(1) The clinical diagnosis of familial DN
syndrome is based primarily on the clinical
assessment of number, distribution, and ap-
pearance of naevi on the entire skin, in combi-
nation with family and personal history.
(2) The histological investigation of a single
naevus does not effectively identify DN syn-
drome patients. The main objective of the his-
tological investigation of a naevus in the clinical
setting ofDN syndrome is to rule out melano-
ma.
(3) Substantial controversy in the his-
topathological literature concerning the pre-
dictive value of criteria or sets of criteria for the
diagnosis of DN is probably related to large
differences in relative prevalence of entities in
series studied or materials received in the diag-
nostic pathology laboratory.
(4) A restrictive approach in the histological
diagnosis of DN is advised, as it results in a
better correlation with personal or family
history of melanoma.
In recent years, genetic studies of familial
DN syndrome kindred have resulted in the
identification of at least two loci, on chromo-
somes 1 and 9,33 associated with the DN
syndrome phenotype. Apparently, there is
genotypic heterogeneity in this syndrome.
Future studies of the genetics ofDN syndrome
may provide clues at the DNA level, which may
hopefully constitute an additional marker in
the pathological diagnosis of sporadic DN.
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